These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28784697)

  • 1. The role of mass spectrometry analysis in bacterial effector characterization.
    Scott NE; Hartland EL
    Biochem J; 2017 Aug; 474(16):2779-2784. PubMed ID: 28784697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in mass spectrometry proteomics for biomedical research.
    Li X; Wang W; Chen J
    Sci China Life Sci; 2017 Oct; 60(10):1093-1113. PubMed ID: 29039124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keeping in Touch with Type-III Secretion System Effectors: Mass Spectrometry-Based Proteomics to Study Effector-Host Protein-Protein Interactions.
    Meyer M; Ryck J; Goormachtig S; Van Damme P
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based proteomic approaches to study pathogenic bacteria-host interactions.
    Yang Y; Hu M; Yu K; Zeng X; Liu X
    Protein Cell; 2015 Apr; 6(4):265-74. PubMed ID: 25722051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-translational Mechanisms of Host Subversion by Bacterial Effectors.
    Scott NE; Hartland EL
    Trends Mol Med; 2017 Dec; 23(12):1088-1102. PubMed ID: 29150361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proteomic future: where mass spectrometry should be taking us.
    Thelen JJ; Miernyk JA
    Biochem J; 2012 Jun; 444(2):169-81. PubMed ID: 22574775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry-based proteomics: basic principles and emerging technologies and directions.
    Van Riper SK; de Jong EP; Carlis JV; Griffin TJ
    Adv Exp Med Biol; 2013; 990():1-35. PubMed ID: 23378000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of LC/MS to proteomics studies: current status and future prospects.
    Chen G; Pramanik BN
    Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics approaches in the quest of kidney disease biomarkers.
    Frantzi M; Bitsika V; Charonis A; Vlahou A
    Prilozi; 2011; 32(2):33-51. PubMed ID: 22286613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical advances in proteomics mass spectrometry: identification of post-translational modifications.
    Amoresano A; Carpentieri A; Giangrande C; Palmese A; Chiappetta G; Marino G; Pucci P
    Clin Chem Lab Med; 2009; 47(6):647-65. PubMed ID: 19426139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics of host-bacterial interactions: new insights from dual perspectives.
    Sukumaran A; Woroszchuk E; Ross T; Geddes-McAlister J
    Can J Microbiol; 2021 Mar; 67(3):213-225. PubMed ID: 33027598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gel-free mass spectrometry-based high throughput proteomics: tools for studying biological response of proteins and proteomes.
    Roe MR; Griffin TJ
    Proteomics; 2006 Sep; 6(17):4678-87. PubMed ID: 16888762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR).
    Wu SL; Kim J; Hancock WS; Karger B
    J Proteome Res; 2005; 4(4):1155-70. PubMed ID: 16083266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry-based proteomics in biomedical research: emerging technologies and future strategies.
    Walsh GM; Rogalski JC; Klockenbusch C; Kast J
    Expert Rev Mol Med; 2010 Sep; 12():e30. PubMed ID: 20860882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry.
    Jensen ON
    Curr Opin Chem Biol; 2004 Feb; 8(1):33-41. PubMed ID: 15036154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ever-increasing necessity of mass spectrometry in dissecting protein post-translational modifications catalyzed by bacterial effectors.
    Jin J; Yuan Y; Xian W; Tang Z; Fu J; Liu X
    Mol Microbiol; 2023 Jun; 119(6):677-686. PubMed ID: 37127430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of cutting-edge proteomics technologies for elucidating host-bacteria interactions.
    Petriz BA; Franco OL
    Adv Protein Chem Struct Biol; 2014; 95():1-24. PubMed ID: 24985768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics in chromatin biology and epigenetics: Elucidation of post-translational modifications of histone proteins by mass spectrometry.
    Sidoli S; Cheng L; Jensen ON
    J Proteomics; 2012 Jun; 75(12):3419-33. PubMed ID: 22234360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry for proteomics-based investigation.
    Woods AG; Sokolowska I; Ngounou Wetie AG; Wormwood K; Aslebagh R; Patel S; Darie CC
    Adv Exp Med Biol; 2014; 806():1-32. PubMed ID: 24952176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEMS 3.0: algorithms and computational tools for tandem mass spectrometry based identification of post-translational modifications in proteins.
    Matthiesen R; Trelle MB; Højrup P; Bunkenborg J; Jensen ON
    J Proteome Res; 2005; 4(6):2338-47. PubMed ID: 16335983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.